Clinical Trials Directory

Trials / Completed

CompletedNCT04255927

Triclosan-antibacterial Sutures Impact on the Incidence of Surgical Site Infection in Laparoscopic Surgeries.

Triclosan-antibacterial Sutures Impact on the Incidence of Surgical Site Infection in Laparoscopic Sleeve Gastrectomy, Laparoscopic Appendectomy or Laparoscopic Cholecystectomy; Multi-center, Double-blind, Randomized Study.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
912 (actual)
Sponsor
ClinAmygate · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Comparing the incidence of PSI in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in laparoscopic sleeve gastrectomy, laparoscopic appendectomy or laparoscopic cholecystectomy.

Detailed description

In this prospective study, we will determine the incidence of PSI in Egypt as well as the impact of using coated polyglactin 910 sutures with Triclosan in lowering the incidence of PSI in laparoscopic sleeve gastrectomy, laparoscopic appendectomy or laparoscopic cholecystectomy.

Conditions

Interventions

TypeNameDescription
DRUGCoated Vicryl plusVicryl plus (Coated Polyglactin 910 with Triclosan)
DRUGCoated vicrylVicryl (Coated Polyglactin 910 without Triclosan)

Timeline

Start date
2020-02-05
Primary completion
2022-03-10
Completion
2022-04-20
First posted
2020-02-05
Last updated
2022-05-11

Locations

1 site across 1 country: Egypt

Regulatory

Source: ClinicalTrials.gov record NCT04255927. Inclusion in this directory is not an endorsement.